Vistagen Therapeutics, Inc. is a late clinical-stage biopharmaceutical company, which engages in developing and commercializing medication and treatment for anxiety, depression, and other central nervous system disorders. Its product portfolio includes Fasedienol (PH94B) nasal spray for social anxiety disorder, Itruvone (PH10) nasal spray for depression disorders, AV-101 oral NMDR glycine site antagonist for depression and neurological disorders, PH15 acute treatment for improvement of cognition, PH80 acute management of vasomotor symptoms due to menopause, and PH284 acute management of Wasting syndrome (Cachexia). The company was founded by H. Ralph Snodgrass and Gordon Keller on May 26, 1998 and is headquartered in South San Francisco, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
41
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Vistagen Therapeutics Inc. market cap is $7.56M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Vistagen Therapeutics Inc. 52 week high is $5.14 as of November 21, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Vistagen Therapeutics Inc. 52 week low is $0.1635 as of November 21, 2026.
Vistagen Therapeutics Inc. stock price today is $0.1636.
Vistagen Therapeutics Inc. stock price yesterday was $0.1866.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Vistagen Therapeutics Inc.'s P/E ratio is -0.12.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Vistagen Therapeutics Inc. P/B ratio is 0.4975.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Vistagen Therapeutics Inc. 50-day moving average is $0.2176.